Features of a subset of children with complex partial epilepsy requiring combination therapy for effective seizure

Matthew E Sloan1, Elisabeth Simard-Tremblay, Michael I Shevell

  • 1Department of Neurology/Neurosurgery, McGill University, Montreal Children's Hospital-McGill University Health Center, Quebec, Canada.

Insights

Children with complex partial seizures and developmental issues, or other seizure types, often need multiple medications. Early identification and combination therapy may improve seizure control in these high-risk pediatric patients.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Clinical Neuroscience

Background:

  • Complex partial seizures (CPS) in children can be challenging to manage.
  • Predicting which children will require multiple antiepileptic drugs (AEDs) is crucial for effective treatment.
  • Suboptimal seizure control impacts quality of life and developmental outcomes.

Purpose of the Study:

  • To identify clinical factors associated with the need for multiple AEDs in pediatric patients with CPS.
  • To stratify risk for suboptimal seizure control in children diagnosed with CPS.
  • To inform treatment strategies for managing CPS in pediatric populations.

Main Methods:

  • Retrospective review of a computerized database from a pediatric neurology practice.
  • Categorization of patients with CPS into two groups: single-medication control (Group 1) vs. multiple-medication control (Group 2).
  • Statistical comparison of clinical characteristics, including seizure types, status epilepticus, and developmental disabilities, between the two groups.

Main Results:

  • Children in Group 2 (multiple AEDs) showed a significantly higher prevalence of status epilepticus, developmental disabilities, and coexisting seizure types compared to Group 1.
  • These factors are indicative of increased risk for difficult-to-control epilepsy.
  • The presence of these comorbidities necessitates closer monitoring and potentially earlier initiation of combination therapy.

Conclusions:

  • Status epilepticus, coexistent seizure types, and developmental disabilities are key indicators for children with CPS at higher risk of requiring multiple AEDs.
  • Proactive identification and closer follow-up of these pediatric patients are recommended.
  • A lower threshold for initiating combination antiepileptic drug therapy should be considered for children with these risk factors to optimize seizure control.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...